Funding and appropriations
Today’s investment in ID research; public health and prevention; and development of new drugs, vaccines and diagnostics will pay significant dividends in the future.
Such investments can prevent needless deaths, dramatically reduce health care costs and improve the quality of life for millions of Americans and others around the world. IDSA supports congressional funding for domestic and international programs, including those at the:
IDSA’s current funding priorities include ID and HIV workforce loan repayment; antimicrobial resistance (surveillance, stewardship, prevention, research and innovation); training and supporting new ID investigators; immunizations; drug, vaccine and diagnostics development; public health infrastructure; preparedness; HIV/AIDS and tuberculosis prevention and treatment; and global health security.
The latest
Loading...
Funding Resources
FY 2026
-
FY 2026 House Letter to HHS and OMB Urging Inclusion of Bio-Preparedness Workforce Pilot Program in President Budget Request pdf
Rep. Trahan led colleagues in sending a letter to the Department of Health and Human Services and Office of Management and Budget urging the inclusion of the Bio- Preparedness Workforce Pilot Program in the FY 2026 President's Budget.
FY 2025
-
FY 2025 House AMR Appropriations Organizational Sign-On Letter pdf
IDSA led 142 organizations in an organizational sign-on letter urging Congress for robust funding for federal AMR programs.
-
FY 2025 House AMR Appropriations Dear Colleague pdf
Signed by over 50 bipartisan representatives and led by Reps. Carter and Pingree urging robust funding for federal AMR programs.
-
Senate FY 2025 AMR Funding Dear Colleague Letter pdf
Signed by 27 senators and led by Sens. Blumenthal and Marshall urging funding for federal infectious diseases programs in FY 2025.
-
House FY 2025 Public Health Workforce Loan Repayment Program and Bio-Preparedness Workforce Pilot Program Multi Organization Sign-On Letter pdf
IDSA led 136 organizations in sending a letter to congressional leaders urging them to fully fund the Public Health Workforce Loan Repayment Program and Bio-Preparedness Workforce Pilot Program.
-
FY 2025 House Bio-Preparedness Workforce Pilot and House Public Health Loan Repayment Programs Appropriations Dear Colleague Letter pdf
House bipartisan letter urging representatives to fund ID/HIV and public health loan repayment programs in FY 2025.
-
FY 2025 Senate Bio-Preparedness Workforce Pilot Program Dear Colleague Letter pdf
Senate bipartisan letter urging the Senate Appropriations Committee to fund ID/HIV loan repayment program in FY 2025.
FY 2024
-
FY 2024 S-FAR AMR Senate Appropriations Letter pdf
IDSA leads over 100 organizations advocating for increased federal funding to combat AMR.
-
FY 2024 House AMR Appropriations Letter pdf
More than 50 representatives join bipartisan letter urging increased funds for the federal AMR response.
-
FY 2024 Senate AMR Appropriations Letter pdf
Twenty-eight senators urge increased federal funding to combat AMR.
-
FY 2024 Public Health Loan Repayment and Bio-Preparedness Pilot Program House Appropriations Letter pdf
IDSA leads over 120 organizations in support of funding for ID/HIV and public health loan repayment.
-
FY 2024 House Bio-Preparedness Workforce Pilot Program Appropriations Letter pdf
Thirty-one representatives join bipartisan letter urging $50 million to launch ID/HIV loan repayment
-
FY 2024 Senate Bio-Preparedness Workforce Pilot Program Appropriations Letter pdf
Sen. Gillibrand and colleagues urge $50 million to launch ID/HIV loan repayment.
Get involved
Join us in our advocacy efforts to make a difference in the fight against infectious diseases. Join the MAP and check out our current advocacy opportunities on the Take Action tab.